SRX sierra rutile holdings limited

Sirt result, page-5

  1. 1,830 Posts.
    lightbulb Created with Sketch. 76
    "Many people speculated that the SARAH study, reported today, was going to miss it's primary endpoint as the group of patients was too mixed."

    Hi PB, can you give us a little more colour behind that statement? It's the first I've heard of it although I admit I'm not that close to the medical community.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.